Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3
about
Neuro-invasion by a 'Trojan Horse' strategy and vasculopathy during intrauterine flavivirus infectionSHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeysThe rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategiesTherapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.Four decades of leading-edge research in the reproductive and developmental sciences: the Infant Primate Research Laboratory at the University of Washington National Primate Research Center.Update on animal models for HIV research.Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques.The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted virusesImmunology of pediatric HIV infectionEarly short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaquesEvidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infectionInitiation of antiretroviral therapy 48 hours after infection with simian immunodeficiency virus potently suppresses acute-phase viremia and blocks the massive loss of memory CD4+ T cells but fails to prevent diseaseNeutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaquesThe role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?Novel ring structure in the gp41 trimer of human immunodeficiency virus type 1 that modulates sensitivity and resistance to broadly neutralizing antibodies.Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers.
P2860
Q24276687-9225EF8E-EE8D-4C5D-9707-B0B35141FEDEQ30372757-A75922A8-AC5B-44F0-92FA-EDB006637A8BQ30374404-EEA501DF-7B6F-4F00-8E30-6B469D9153FEQ33597744-B682CDE5-F266-48DB-BD7C-4EE569CCAC15Q33750568-B9F4D7AB-46C5-4A3D-92EA-FC4A1FDDF14BQ33835488-EFCC6240-5DE1-43D2-9310-FA9AC325EBE8Q34185625-DE44DF0D-346D-499F-8F00-AFBDAD8D55CAQ36974671-440A2E4E-E1BB-44E8-888D-1D4C09ED73FDQ37080573-BE685AC7-3CF1-4ECE-AC5A-418DE7917F14Q37171570-A542F64E-F3CB-4BEE-A5C1-2710A64EB4A2Q37247875-3E9F5154-6332-429E-87F4-EA7BB1BB3050Q37248025-C6E588A1-0F52-4538-8A88-D15537916749Q37252831-35289689-4D6F-457B-8921-4D02EF3F6CD7Q37365618-B69FACF5-558C-449B-8145-1EDAEB7A7D2BQ43096886-3F010FBE-0A95-44BF-8288-AA1850D55757Q43215260-10F2F962-F117-4DB0-B294-CF90680BFEDC
P2860
Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Evidence for persistent, occul ...... immunodeficiency virus SF162P3
@ast
Evidence for persistent, occul ...... immunodeficiency virus SF162P3
@en
type
label
Evidence for persistent, occul ...... immunodeficiency virus SF162P3
@ast
Evidence for persistent, occul ...... immunodeficiency virus SF162P3
@en
prefLabel
Evidence for persistent, occul ...... immunodeficiency virus SF162P3
@ast
Evidence for persistent, occul ...... immunodeficiency virus SF162P3
@en
P2093
P2860
P356
P1433
P1476
Evidence for persistent, occul ...... immunodeficiency virus SF162P3
@en
P2093
Barbra A Richardson
David Anderson
Deepika Mohan
LaRene Kuller
Lynda Misher
Nancy L Haigwood
Patricia Polacino
Pushpa Jayaraman
Shiu-Lok Hu
P2860
P304
P356
10.1128/JVI.01759-06
P407
P577
2006-11-01T00:00:00Z